In malignancy, elevated αSMA and reduced E-cadherin expression mark the EMT91, while pseudo-epitheliomatous hyperplasia typically maintains E-cadherin levels, making E-cadherin as a differentiating marker between oral squamous cell carcinoma and pseudo-epitheliomatous hyperplasia92,93. Here, CDH1 is linked to oral cavity squamous cell carcinoma.